Stay updated on Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A notice appears above the study record stating that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence.” The study record itself remains an error page.
    Difference
    1%
    Check dated 2026-10-25T15:25:01.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2. The page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:35:35.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T22:30:45.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record, indicating restricted access. The error page includes the standard header and footer, with a 403 message where the study details would appear.
    Difference
    0.6%
    Check dated 2026-09-27T22:45:33.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study content, effectively replacing the study details and navigation with an error message and site chrome.
    Difference
    20%
    Check dated 2026-09-20T20:38:00.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new funding attribution for 2016 (U.S. NIH Grant/Contract) has been added, and the site revision has been updated from v3.6.5 to v3.6.6, indicating a minor version update.
    Difference
    0.1%
    Check dated 2026-08-30T17:10:12.000Z thumbnail image

Stay in the know with updates to Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.